Evidence map›Paper›PMID 30049598›Full record

ArticleThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2018

Stopping Cognitive Decline in Patients With Late-Life Depression: A New Front in the Fight Against Dementia.

Eric J Lenze, Aristotle N Voineskos, Meryl A Butters, Jordan F Karp, OPTIMUM and OPTIMUM-Neuro collaborative team

Abstract readEditorialComment
In one paragraph

Article in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Eric J LenzeWashington University School of Medicine, St. Louis, MO. Electronic address: lenzee@wustl.edu.
Aristotle N VoineskosUniversity of Toronto, Toronto, Ontario.
Meryl A ButtersUniversity of Pittsburgh, Pittsburgh, PA.
Jordan F KarpUniversity of Pittsburgh, Pittsburgh, PA.
OPTIMUM and OPTIMUM-Neuro collaborative team

Funding

3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depressionR01MH114969 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BUTTERS, MERYL A · 2017 to 2021
$2.6M
1/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment-resistant late-life depressionR01MH114970 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI VOINESKOS, ARISTOTLE NICHOLAS · 2017 to 2021
$2.0M
2/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression.R01MH114980 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BROWN, PATRICK J, RUTHERFORD, BRET R · 2017 to 2021
$1.8M
5/5 Neurocognitive and neuroimaging biomarkers: predicting progression toward dementia in patients with treatment resistant late-life depressionR01MH114966 · NIMH · WASHINGTON UNIVERSITY · PI SHIMONY, JOSHUA S · 2017 to 2021
$1.7M
NIMH NIH HHS R01 MH114966NIMH NIH HHS R01 MH114969NIMH NIH HHS R01 MH114970NIMH NIH HHS R01 MH114980
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer DiseaseCognitive DysfunctionDementiaDepressive DisorderAgedDepressionHumans

Identifiers

PMID30049598
PMCPMC6633901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.